2. Immunology/Inflammation
  3. NOD-like Receptor (NLR)
  4. NLRP3-IN-45

NLRP3-IN-45 (D6) 是 NLRP3 炎症小体活化的抑制剂，抑制 IL-1β 的活性 (IC50=41.79 nM)。NLRP3-IN-45 不影响 NLRP3 炎症小体激活的起始阶段。NLRP3-IN-45 在 LPS 诱导的急性肺损伤 (ALI) 小鼠模型中特异性抑制 NLRP3 炎症小体的激活。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

NLRP3-IN-45 Chemical Structure

NLRP3-IN-45 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

NLRP3-IN-45 相关抗体

Top Publications Citing Use of Products

查看 NOD-like Receptor (NLR) 亚型特异性产品:

查看所有亚型
NLRP3 NLRP1 NOD1 NOD2

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

NLRP3-IN-45 (D6) is an inhibitor of NLRP3 inflammasome activation, inhibiting the activity of IL-1β (IC50=41.79 nM). NLRP3-IN-45 exerts its effects without affecting the initial stage of NLRP3 inflammasome activation. NLRP3-IN-45 specifically inhibits the activation of NLRP3 inflammasome in the LPS-induced acute lung injury (ALI) mouse model[1].

IC50 & Target

NLRP3 inflammasome

 

体外研究
(In Vitro)

NLRP3-IN-45 (0.2-5 μM，1 h) 在 BMDMs 细胞中可抑制 NLRP3 炎症小体的激活，且不影响 AIM2 和 NLRC4 炎症小体的激活[1]。
NLRP3-IN-45 (0.2-5 μM，1 h) 不影响 NLRP3 炎症小体激活的启动阶段[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

NLRP3-IN-45 相关抗体:

Western Blot Analysis[1]

Cell Line: a NLRP3 inflammasome model in BMDMs cells; a AIM2 and NLRC4 inflammasome model in BMDMs cells
Concentration: 0.2, 1, 5 μM
Incubation Time: 1 h
Result: Inhibited the secretion of IL-1β and Caspase-1 mediated by NLRP3 inflammasome in a concentration-dependent manner[1].
Had no significant effect on the expression of TNF-α, Pro-IL-1β, Pro-caspase-1, NLRP3 and ASC proteins[1].
Had no effect on the secretion of IL-1β and Caspase-1 mediated by AIM2 and NLRC4 inflammasome[1].
体内研究
(In Vivo)

NLRP3-IN-45 (0.1-10 mg/kg，一天一次，3天，腹腔注射) 在急性肺损伤小鼠模型中抑制 NLRP3 炎性体的激活，对急性肺损伤有保护作用[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: LPS-induced ALI mice[1]
Dosage: 0.1, 1, 10 mg/kg; once a day; 3 days
Administration: Intraperitoneal injection (i.p.)
Result: Made the mice appear more active and the mice lost weight[1].
Reduced serum levels of IL-6, TNF-α, IL-1β, and BALF in a dose-dependent manner[1].
Weakened lung tissue lesions and significantly inhibited the secretion of IL-1β and Caspase-1 mediated by NLRP3 inflammasome activation[1].
分子量

483.53

Formula

C27H30FNO6
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

NLRP3-IN-45 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

NLRP3-IN-45NOD-like Receptor (NLR)A NLRP3 inflammasome model in mouseAcute lung injuryInflammasome activationInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
NLRP3-IN-45
目录号：
HY-168009
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z